Development and Validation of the Modified Version of VascuQol Scale in Patients With Lower Extremity Peripheral Arterial Disease.
Recruiting now
Conditions studied: Peripheral Arterial Disease
In brief
The purpose of this study is to assess the utility of the Modified version of VascuQol Scale as an effective biopsychosocial assessment tool for patients suffering from lower extremity peripheral arterial disease.
Key facts
- Study ID
- NCT06223217
- Run by
- RenJi Hospital
- People needed
- 480
- Starts
- 2023-10-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2024-01-25
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female aged 18-90
- The patient is diagnosed with lower extremity peripheral arterial disease
- The patient is willing to comply with specified follow-up evaluations at the specified times
- The patient understands the nature of the procedure and provides written informed consent before enrolment in the study
- Before enrolment, the guidewire has crossed the target lesion
- No restrictions on Rutherford grading, TASC grading, GLASS grading
You may not qualify if…
- Pregnant women or Female patients with potential childbearing
- The patient is currently participating in another investigational drug or device study that has not reached the primary endpoint.
- Patients unwilling or refusing to sign informed consent
- Patients with other diseases that may seriously affect the quality of life, such as tumors, severe liver disease, cardiac insufficiency, etc., or those with a life expectancy of less than 2 years
Where it is running
- Renji Hospital — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.